IOF Committee of National Societies Medal awarded to Dr. Elias Hanna Saba

April 17, 2016

Malaga, Spain, April 17, 2016

Dr Elias Hanna Saba, Chief Executive Director of the Palestinian Osteoporosis Prevention Society (POPS), was awarded the International Osteoporosis Foundation's (IOF) Committee of National Societies (CNS) Medal during the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016).

The CNS Medal recognizes an individual who has made an important contribution to the cause of osteoporosis prevention through active participation in CNS activities and by expanding IOF's messages and outreach in his/her country. The CNS, comprising 234 patient and medical societies worldwide, is IOF's core membership committee. Its membership represents the world's largest single network of national and regional organizations dedicated to the prevention of osteoporosis and related musculoskeletal disorders.

Professor Jean-Yves Reginster, Chair of the CNS and IOF Board member presented the medal to Dr Saba, and commented: "With his more than 26-years of experience in the field of bone and muscle health, and his longstanding dedication to patient and health professional education, Dr Saba is one of the most respected osteoporosis advocates in the Middle East region. As representative of the Palestinian Osteoporosis Patient Society, he has continually demonstrated great commitment in IOF's CNS. He is a truly deserving recipient of this third edition of this important award."

Dr Saba is the Director of the Bone and Muscle Health Center in Hebron (under establishment). He was formerly the Head of Rheumatology and Rehabilitation, and Director of the Palestinian Osteoporosis Diagnostic Center in Bethlehem. In addition to his leadership of the Palestinian Osteoporosis Prevention Society, Dr Saba is also Board member, past President and former General Secretary of the Pan Arab Osteoporosis Society (PAOS).
-end-
About the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO 2016) :

Held jointly by IOF and ESCEO, the Congress is taking place in Malaga, Spain from April 14-17,2016. It is the world's largest annual forum for the presentation of clinical research and new advances in the prevention and management of bone, muscle and joint disorders, including sarcopenia and frailty. The next Congress will be held in Florence, Italy from March 23-26, 2017. For complete information visit http://www.wco-iof-esceo.org #OsteoCongress

About IOF :

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers, leading companies, as well as more than 234 patient, medical and research societies in 99 locations, work together to make bone, joint and muscle health a worldwide heath care priority. http://www.iofbonehealth.org / http://www.facebook.com/iofbonehealth / https://twitter.com/iofbonehealth

About ESCEO :

The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.esceo.org

International Osteoporosis Foundation

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.